Identification of differentially expressed genes related to NF1-associated malignant transformation from a patient with neurofibromatosis type 1

Genes and Genomics

Volumn 30, Issue 4, 2008, Pages 407-418

  Jeong, Seon Yong ^a   Han, Jae Ho ^a   Park, Yong Yea ^a   Kim, Hyon J ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

DEG; Interferon ; Malignant transformation; MPNST; Neurofibromas; Neurofibromatosis type 1 (NF1); Tumor progression

Indexed keywords

EID: 51749091733     PISSN: 19769571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K and Aldaz CM (2004) Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res. 6: R499-513.
2. Akyerli CB, Beksac M, Holko M, Frevel M, Dalva K, Ozbek U, Soydan E, Ozcan M, Ozet G, Ilhan O, et al. (2004) Expression of IFITM1 in chronic myeloid leukemia patients. Leuk. Res. 29: 283-286.
3. Assinder SJ, Stanton JA and Prasad PD (2008) Transgelin: An actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol. in press.
4. Binder BR and Mihaly J (2008) The plasminogen activator inhibitor "paradox" in cancer. Immunol. Lett. in press.
5. Cerignoli F, Quo X, Cardinali B, Rinaldi C, Casaletto J, Frati L, Screpanti I, Gudas LJ, Gulino A, Thiele CJ, et al. (2002) retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines. Cancer Res. 62: 1196-1204.
6. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low PS, Rouleau GA, Mohandas N, et al. (1998) The PERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 23: 281-282.
7. DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D and Ratner N (2000) Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J. Clin. Invest. 105: 1233-1241.
8. den Hollander P and Kumar R (2006) Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells. Cancer Res. 66: 5941-5949.
9. Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS and Clark MA (2004) Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 100: 826-833.
10. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E and Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J. Med. Genet. 39: 311-314.
11. Ferner RE and Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res. 62: 1573-1577.
12. Friedman JM (1999) Epidemiology of neurofibromatosis type 1. Am. J. Med. Genet. 89: 1-6.
13. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M and Nakamura Y (2001) Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a down-stream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res. 61: 7722-7726.
14. Gál P, Ambrus G and Závodszky P (2002) C1s, the protease messenger of C1. Structure, function and physiological significance. Immunobiology 205: 383-394.
15. Givant-Horwitz V, Davidson B and Reich R (2005) Laminin-induced signaling in tumor cells. Cancer Lett. 223: 1-10.
16. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A and Watson MA (2002) Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res. 62: 2085-2091.
17. Holtkamp N, Mautner VF, Friedrich RE, Harder A, Hartmann C, Theallier-Janko A, Hoffmann KT and von Deimling A (2003) Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors. Acta. Neuropathol. 107: 159-68.
18. Holtkamp N, Reuss DE, Atallah I, Kuban RJ, Hartmann C, Mautner VF, Frahm S, Friedrich RE, Algermissen B, Pham VA, et al. (2004) Subclassification of nerve sheath tumors by gene expression profiling. Brain Pathol. 14: 258-264.
19. Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P and Ohgaki H (2000) Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res. 60: 6868-6874.
20. Huson SM (1994) Neurofibromatosis 1: a clinical and genetic overview. In the neurofibromatosis. Huson and Hughes RAC, eds. Chapman and Hall Medical, London, pp. 160-203.
21. Hwang IT, Kim YJ, Kim SH, Kwak Cl, Gu YY and Chun JY (2003) Annealing control primer system for improving specificity of PCR amplification. Biotechniques 35: 1180-1184.
22. Jeong SY, Park SJ and Kim HJ (2006) The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1. J. Korean Med. Sci. 21: 107-112.
23. Johannessen CM, Reczek EE, James MF, Brems H, Legius E and Cichowski K (2005) The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc. Natl. Acad. Sci. USA 102: 8573-8578.
24. Kim YJ, Kwak CI, Gu YY, Hwang IT and Chun JY (2004) Annealing control primer system for ident fication of differentially expressed genes on agarose gels. Biotechniques 36: 424-426.
25. Kindblom LG, Ahldén M, Meis-Kindblom JM and Stenman G (1995) Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours. Virchows Arch. 427: 19-26.
26. Koga T, Iwasaki H, Ishiguro M, Matsuzaki A and Kikuchi M (2002) Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis. J. Pathol. 197: 98-107.
27. Kosaka H, Yoshimoto T, Yoshimoto T, Fujimoto J and Nakanishi K (2008) Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat. Med. 14: 437-441.
28. Kourea HP, Cordon-Cardo C, Dudas M, Leung D and Woodruff JM (1999) Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas. Am. J. Pathol. 155: 1885-1891.
29. Lee MJ and Stephenson DA (2007) Eecent developments in neurofibromatosis type 1. Curr. Opin. Neurol. 20: 135-141.
30. Lee PR, Cohen JE, Tendi EA, Farrer R, DE Vries GH, Becker KG and Fields RD (2004) Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells. Neuron Glia. Biol. 1: 135-147.
31. Levy P, Bièche I, Leroy K, Parfait B, Wechsler J, Laurendeau I, Wolkenstein P, Vidaud M and Vidaud D (2004a) Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Clin. Cancer Res. 10: 3763-3771.
32. Lévy P, Vidaud D, Leroy K, Laurendeau I, Wechsler J, Bolasco G, Parfait B, Wolkenstein P, Vidaud M and Bièche I (2004b) Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Mol. Cancer 13: 398-407.
33. Lévy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B, Leroy K, Wechsler J, Salmon I, Wolkenstein P, et al. (2007) Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin. Cancer Res. 13: 398-407.
34. Linder S (2007) Cytokeratin markers come of age. Tumor Biol. 28: 189-195.
35. Meehan S, Wu AJ, Kang EC, Sakai T and Ambudkar IS (1997) Interferon-gamma induces a decrease in the intracellular calcium pump in a human salivary gland cell line. Am. J. Physiol. 273: C2030-2036.
36. Miller SJ, Rangwala F, Williams J, Ackerman P, Kong S, Jegga AG, Kaiser S, Aronow BJ, Frahm S, Kluwe L, et al. (2006) Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res. 66: 2584-2591.
37. Nakayama J, Tanaka T, Arakawa F, Terao H, Shimura H, Ikeda S and Kuroki M (2003a) Gamma interferon gene transfection efficiently inhibits proliferation of neurofibroma cell lines in vitro. J. Dermatol. 30: 181-188.
38. Nakayama J, Tanaka T, Furumura M, Takahashi A, Yamaguchi T, Shimura H, Ikeda S and Kuroki M (2003b) Inhibition of the proliferation of a malignant peripheral nerve sheath tumor cell line by gamma interferon gene transfection. J. Dermatol. 30: 879-885.
39. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE and Louis DN (1999) Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am. J. Pathol. 155: 1879-1884.
40. North K (2000) Neurofibromatosis Type 1. Am. J. Med. Genet. 97: 119-127.
41. Pasco S, Brassart B, Ramont L, Maquart FX and Monboisse JC (2005) Control of melanoma cell invasion by type IV collagen. Cancer Detect. Prev. 29: 260-266.
42. Perrone F, Tabano S, Colombo F, Dagrada G, Birindelli S, Gronchi A, Colecchia M, Pierotti MA and Pilotti S (2003) p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Clin. Cancer Res. 9: 4132-4138.
43. Prasad V, Boivin GP, Miller ML, Liu LH, Erwin CR, Warner BW and Shull GE (2005) Haploinsufficiency of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. Cancer Res. 65: 8655-8661.
44. Savar A and Cestari DM (2008) Neurofibromatosis type I: genetics and clinical manifestations. Semin. Ophthalmol. 23: 45-51.
45. Shannan B, Seifert M, Boothman DA, Tilgen W and Reichrath J (2006) Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. J. Mol. Histol. 37: 183-188.
46. Watanabe T, Oda Y, Tamiya S, Masuda K and Tsuneyoshi M (2001) Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components. J. Clin. Pathol. 54: 631-636.
47. Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R and Gutmann DH (2004) Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type 1-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol. 14: 297-303.
48. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, et al. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608.
49. Yang G, Xu Y, Chen X and Hu G (2007) IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 26: 594-603.